(Total Views: 287)
Posted On: 04/02/2017 7:54:31 PM
Post# of 15624
Therapix Biosciences, a pharma company specializing in the development and commercialization of cannabinoid-based drugs, on Tuesday announced the successfully completion of the development phase of a unique formulation of a tablet for sublingual administration for pharmaceutical use.
(0)
(0)
